What is a hemangioma?
What causes hemangiomas?
Who gets hemangiomas?
How do hemangiomas cause disease?
What are the common findings of hemangiomas?
How are hemangiomas diagnosed?
What are the complications of hemangiomas?
How are hemangiomas prevented?
What research is being performed?
Are there links to other information?
by Joseph Morelli, M.D.
Associate Professor of Dermatology and Pediatrics
University of Colorado School of Medicine
A hemangioma is a benign tumor of the blood vessels ("capillary endothelium"). Some
hemangiomas occur as birthmarks, often spontaneously improving.
The cause of hemangiomas is unknown.
Hemangiomas are a very common benign tumor of infancy. Hemangiomas occur in up to
10% of the population, most commonly in females and in premature infants.
Because they are tumors, hemangiomas have a mass effect, meaning they take up space
or room, which is caused by the growth of the tumor.
Only 20% of hemangiomas are present at birth. The other 80% occur during the first
two months of life, usually within the first month. They appear as white-gray blue
flat spots, swollen "spider veins" (telangiectasias), or raised bumps. Then, they
undergo a rapid growth phase, lasting from six to nine months, in which they grow
faster than the child's rate of growth. After this time, the growth of the hemangioma
slows and approximates the growth rate of the child. The stable growth phase lasts
until 12 to 18 months of age at which time the hemangioma begins to undergo "involution."
During the involution phase, the tumor shrinks on its own, without the need for
treatment. Maximum shrinkage occurs in 50% of children by age 5, in 70% of children
by age 7, and in 90% of children by age 9.
Parents should know that hemangiomas do not always completely disappear; in some
cases, the affected skin does not return to its normal appearance.
Some hemangiomas leave recognizable marks following shrinkage of the tumor. These
include decreased skin color; spider veins; excess lax skin; fibrous fatty deposits;
and scarring, if the skin has broken down over the hemangioma.
Hemangiomas can appear as three different forms. The first type is the superficial
bright red form, formerly known as the strawberry mark. The second type is the deep
blue nodule, formerly known as a cavernous hemangioma. The third type is a combination
of the superficial and the deep forms, which is called a mixed hemangioma. Commonly,
the terms "superficial," "deep," and "mixed" are used to describe the three different
types of hemangiomas.
Hemangiomas usually are diagnosed based on an examination and the history of the
lesion. Occasionally, magnetic resonance imaging is performed to determine the depth
of involvement of the tumor; however, this procedure is rarely necessary or helpful.
Most hemangiomas are uncomplicated and do not require treatment. Complications of
hemangiomas include ulceration (a breakdown of the overlying skin), infection, interference
with a vital function, and, even, high output cardiac failure. Initially, the Kasabach-Merritt
syndrome, which is a bleeding disorder, was thought to occur with hemangiomas; however,
now, it is thought to occur with hemangioendotheliomas, which are a much less common
and more aggressive tumor. Ulceration is the most common complication of hemangiomas.
Ulcerated hemangiomas occur most commonly on the lip and in the diaper areas. If
a lesion is ulcerated, it is at risk for infection. Staphylococcus aureus is the
most common bacteria in infected hemangiomas. Vision, breathing, eating, urination,
and bowel movements may all be obstructed by large, rapidly growing hemangiomas.
Most hemangiomas do not require treatment. Ulcerated hemangiomas are best treated
with a specific type of laser. This leads to rapid healing of the open area. Infection
is treated with specific antibiotics for Staphylococcus aureus. Large, rapidly growing
hemangiomas, or hemangiomas that interfere with a vital function, are treated with
systemic therapy. (Systemic therapy is treatment that affects the whole body, as
opposed to localized treatment, and can be given either by mouth or intravenous
injection.) Prednisone is the initial treatment of choice. It usually is given for
two weeks. If after two weeks of therapy the tumor growth has been slowed, treatment
is then tapered over the next four weeks. If there is no initial effect of therapy,
the dose of prednisone is maintained for another two weeks. The patient should be
seen every two weeks during therapy. Occasionally, after therapy is stopped, there
will be some rebound growth of the tumor. If this growth is substantial, therapy
should be restarted. Interferon-alfa also has been used to treat hemangiomas. The
use of interferon-alfa should be reserved for hemangiomas that do not respond to
Currently, hemangiomas cannot be prevented.
The research most applicable to hemangiomas is being performed in the area of inhibiting
the formation of new blood vessels (anti-angiogenesis). Since hemangiomas are vascular
tumors, any therapy that inhibits blood vessel formations should impede hemangioma
growth. At this time, agents that inhibit blood vessel formation have not yet been
used for hemangioma therapy.
A support group for families with children with hemangiomas is available at: The
National Organization of Vascular Anomalies, P.O. Box 0358, Findlay, OH 45839-0358,
phone number: (419) 425-1593, e-mail: email@example.com and on the web at www.novanews.org.
Rasmussen JE. Vascular birthmarks in children. Dermatology Nursing 10:169-177, 1998.
Frieden IJ. Which hemangiomas to treat-and how? Arch Dermatol 133:1593-1595, 1997.
Morelli JG. Hemangiomas and vascular malformations. Pediatric Annals 25:91-96, 1996.
About the Author
Joseph received his undergraduate degree from the University of Pennsylvania, graduating
Summa cum Laude with honors in biophysics. He completed his medical school training
in 1981 from the Harvard University School of Medicine.
He is board certified in pediatrics and dermatology and completed his residencies
in the same specialties. Joseph is a Pediatric Dermatologist with major interest
in birthmarks and vascular lesions.
He spends most of his free time coaching Little League Baseball and Midget Football!
Copyright 2012 Joseph Morelli, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
If you think that you are having a medical emergency,
call 911 or the number for the local emergency ambulance service NOW!
And when in doubt, call your doctor NOW
or go to the closest emergency department.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
Acquisition of Information through PMD
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
Your Doctor's Right to Privacy
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
Disclosure to Third Parties
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
Privacy and Our Business Partners
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at firstname.lastname@example.org. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at email@example.com.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at firstname.lastname@example.org. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
Contacting the Website
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at email@example.com or by mail at our address above.